Midazolam Hydrochloride
Product Images NDC 55648-763

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Midazolam Hydrochloride (NDC 55648-763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Midazolaminjwp M Figure 01)

Chemical structure of Midazolam hydrochloride, showing fused aromatic and nitrogen-containing rings with a chlorine and fluorine substituent, and a methyl group, accompanied by hydrochloride (HCl).*

FDA Label Image

Structure (Midazolaminjwp M Figure 02)

Chemical structures showing the equilibrium between Midazolam and its open-ring form. The diagram depicts the two molecular forms with labeled structural differences, illustrating the dynamic ring-opening of Midazolam hydrochloride.*

FDA Label Image

Chart (Midazolaminjwp M Figure 03)

A line graph showing the pH dependence of the open-ring form of Midazolam hydrochloride in water. The x-axis represents pH ranges from 2.5 to 5.5, and the y-axis shows the percentage of the open-ring form, decreasing sharply as pH increases.*

FDA Label Image

Label (Midazolaminjwp M Figure 04)

Label for Midazolam hydrochloride Injection, USP, 2 mg/2 mL (1 mg/mL) supplied as a 2 mL vial. The label states it contains benzyl alcohol, is for intramuscular (I.M.) or intravenous (I.V.) use only, and is Rx only. Manufactured by Wockhardt Limited, India, and distributed by Wockhardt USA LLC, New Jersey, USA. The label includes NDC 64679-762-07 and a barcode.*

FDA Label Image

Label (Midazolaminjwp M Figure 05)

Midazolam HCl Injection, USP label displaying 50 mg per 10 mL (5 mg/mL) strength in a 10 mL vial. The sterile injectable product is marked for intramuscular or intravenous use only and is manufactured by Wockhardt Limited. The label notes the presence of 0.01% edetate disodium, 1% benzyl alcohol preservative, and sodium chloride content with pH adjustment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.